Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for preparing cefixime dispersible tablet raw material intermediate

A technology of cefixime and dispersible tablets, which is applied in the field of preparation of pharmaceutical intermediates, can solve the problems of high raw material cost, many wastes, and low yield, and achieve high production value, low cost, and short reaction cycle

Active Publication Date: 2010-12-29
GUANGDONG XIANQIANG PHARMA +2
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as the market continues to change, the cost of the original process can no longer meet the needs of the market. Generally, there are disadvantages such as long cycle, many wastes, high cost of raw materials and low yield.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing cefixime dispersible tablet raw material intermediate
  • Method for preparing cefixime dispersible tablet raw material intermediate
  • Method for preparing cefixime dispersible tablet raw material intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Cefixime intermediate preparation method:

[0016]

[0017] Add 100g of tert-butyl acetoacetate and 100ml of glacial acetic acid to a 2000ml round bottom flask, add dropwise 100ml of water and 30g of NaNO 2 For the prepared solution, the rate of addition is controlled so that the temperature of the system does not exceed 40°C. After the addition, react at 15°C for 30 minutes. Evaporate most of the HOAC under reduced pressure, add appropriate amount of methyl chloroacetate and anhydrous K 2 CO 3 , Stir the reaction at room temperature for 10h. After the reaction is complete, add 800ml of water, add 400ml of EtOAc, separate the liquid, transfer the oil to a 1000ml flask, add 150ml of HOAc, add 200g of sulfuryl chloride dropwise at 20°C within 1h, after the drop is complete, react at this temperature for another 1h. Cool, concentrate under reduced pressure, and dry under vacuum at 50°C to obtain 36.3 g of white crystals with a measured content of 99.7%.

Embodiment 2

[0019]

[0020] Add 100g of tert-butyl acetoacetate and 100ml of 1mol / L hydrochloric acid in a 2000ml round bottom flask, add dropwise 100ml of water and 30g of KNO 2 For the prepared solution, the rate of addition is controlled so that the temperature of the system does not exceed 40°C. After the addition, react at 15°C for 30 minutes. Evaporate most of the HCl under reduced pressure, add appropriate amount of methyl chloroacetate and anhydrous K 2 CO 3 , Stir the reaction at room temperature for 10h. After the reaction, add 1000ml of water, add 400ml of EtOAc, separate the oily matter into a 1000ml flask, add 100ml of H 3 PO 4 , Add 180 g of sulfonyl chloride dropwise within 2 hours at 25°C, after the drop is complete, react at this temperature for another 2 hours. Cool, concentrate under reduced pressure, and dry under vacuum at 50°C to obtain 34.3 g of white crystals with a measured content of 101.2%.

Embodiment 3

[0022]

[0023] Add tert-butyl acetoacetate 100g, 1mol / L hydrochloric acid 100ml in the 2000ml round-bottomed flask, drop by 100ml water and 26g Ca(NO 2 ) 2 For the prepared solution, the rate of addition is controlled so that the temperature of the system does not exceed 40°C. After the addition, react at 15°C for 30 minutes. Evaporate most of HOAc under reduced pressure, add appropriate amount of methyl chloroacetate and anhydrous Na 2 CO 3 , Stir the reaction at room temperature for 8h. After the reaction is complete, add 500ml of water, add 400ml of EtOAc, separate the oil and transfer it to a 1000ml flask, add 100ml of HOAc, add 160g of sulfuryl chloride dropwise at 25°C within 2h, and then react at this temperature for another 2h. Cool, concentrate under reduced pressure, and dry under vacuum at 50°C to obtain 38.1 g of white crystals with a measured content of 99.1%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing a cefixime dispersible tablet raw material intermediate, namely (Z)-4-chlorine-methoxycarbonylmethoxyimine-3-oxo-butanoic acid. The intermediate is prepared from a raw material t-butyl acetoacetate by three steps of reaction, namely nitrosification, esterification and halogenation. The preparation method has the advantages of simple and convenient synthetic technology, high yield, low cost, and suitability for industrial production.

Description

technical field [0001] The present invention relates to the preparation method of pharmaceutical intermediate, more specifically, relate to the raw material intermediate of cefixime dispersible tablet namely (Z)-4-chloro-2-methoxycarbonylmethoxyimine-3-oxobutanol Acid synthesis preparation method. technical background [0002] (Z)-4-Chloro-2-methoxycarbonylmethoxyimine-3-oxobutanoic acid is synthesized from (6R, 7R)-7-[(Z)-2-(2-amino-4- Thiazolyl)-2-(carboxymethoxyimino)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- Carboxylic acid trihydrate (referred to as cefixime) key intermediate, cefixime is a third-generation cephalosporin, which must be effective against gram-positive streptococci, pneumococcus and gram-negative , Serratia, Proteus, and Haemophilus influenzae have killing effects, are stronger than other oral cephalosporins, and are resistant to enzymes. Clinically used to treat acute and chronic bronchitis, pneumonia, urethritis, cystitis, pyelon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C251/60C07C249/06
Inventor 王玉生沈小钟张志生邱亚平严振张现涛
Owner GUANGDONG XIANQIANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com